Literature DB >> 27347194

Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment.

Jing Zhang1, Dingqi Sun2, Qiang Fu2, Qingwei Cao2, Hui Zhang2, Keqin Zhang2.   

Abstract

The aim of the present study was to investigate the tropism of mesenchymal stem cells (MSCs) to the tumor microenvironment, and to evaluate the feasibility of bone marrow mesenchymal stem cells differentiating into myofibroblasts in vitro. A total of 1 ml bone marrow was extracted from the greater trochanter of one male New Zealand rabbit, and MSCs were obtained by density gradient centrifugation and cultured routinely. The surface markers were analyzed by flow cytometry. A VX2 tumor was aseptically excised from another male New Zealand rabbit and primary cultured. The tropism of MSCs for 30% and 50% VX2 conditioned medium was determined by using Transwell migration assays. MSCs were incubated in 30% VX2 conditioned medium for 7 or 14 days. The messenger (m)RNA levels and protein expression of α-smooth muscle actin (α-SMA) and vimentin were measured by reverse transcription-polymerase chain reaction and western blotting. MSCs were observed to have a spindle shape. The cultured MSCs were cluster of differentiation (CD)44+, CD105+, CD106+ and CD34-. VX2 cells demonstrated a spindle or polygon shape. In the Transwell assay, it was observed that the migrated cells appeared more frequently in the 30% VX2 conditioned medium group compared with the other groups when microscopically examined, which was additionally confirmed by the results of a colorimetric assay. The mRNA levels and protein expression of α-SMA and vimentin significantly increased in the test group compared with the control group at 7 days (P<0.01), and further increased in the test group at 14 days (P<0.01). The results of the present study demonstrated that MSCs have tropism for the tumor microenvironment and furthermore, may differentiate into myofibroblasts in the tumor microenvironment in vitro. The present study suggested that MSCs may migrate to the tumor and subsequently differentiate into myofibroblasts due to the tumor microenvironment, which may lead to promotion of the growth of the tumor. The present study additionally suggested that MSCs may be the precursors of tumor/carcinoma-associated myofibroblasts.

Entities:  

Keywords:  bone marrow mesenchymal stem cells; differentiation; myofibroblast; tumor microenvironment

Year:  2016        PMID: 27347194      PMCID: PMC4907309          DOI: 10.3892/ol.2016.4645

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

Review 1.  Tumor microenvironment: the role of the tumor stroma in cancer.

Authors:  Hanchen Li; Xueli Fan; Jeanmarie Houghton
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

2.  Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.

Authors:  Valerie P J Saw; Enno Schmidt; Ifeoma Offiah; Grazyna Galatowicz; Detlef Zillikens; John K G Dart; Virginia L Calder; Julie T Daniels
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity.

Authors:  A Schmitt-Gräff; A Desmoulière; G Gabbiani
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis.

Authors:  Ivy A W Ho; Yulyana Yulyana; Kian C Sia; Jennifer P Newman; Chang M Guo; Kam M Hui; Paula Y P Lam
Journal:  FASEB J       Date:  2014-06-30       Impact factor: 5.191

5.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Joachim C Mertens; Christian D Fingas; John D Christensen; Rory L Smoot; Steven F Bronk; Nathan W Werneburg; Michael P Gustafson; Allan B Dietz; Lewis R Roberts; Alphonse E Sirica; Gregory J Gores
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

Review 6.  Role of oxidative stress and the microenvironment in breast cancer development and progression.

Authors:  Agnieszka Jezierska-Drutel; Steven A Rosenzweig; Carola A Neumann
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

7.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Authors:  Pravin J Mishra; Prasun J Mishra; Rita Humeniuk; Daniel J Medina; Gabriela Alexe; Jill P Mesirov; Sridhar Ganesan; John W Glod; Debabrata Banerjee
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.

Authors:  Kanupriya Gupta; Rashmi Metgud; Jatin Gupta
Journal:  J Cancer Res Ther       Date:  2015 Oct-Dec       Impact factor: 1.805

Review 9.  Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.

Authors:  Urszula M Polanska; Akira Orimo
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

10.  Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus.

Authors:  P ROUS; J G KIDD; W E SMITH
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

View more
  3 in total

1.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

2.  Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration.

Authors:  Zhengliang Xu; Wenjing Yin; Yuelei Zhang; Xin Qi; Yixuan Chen; Xuetao Xie; Changqing Zhang
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

3.  Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry.

Authors:  Valeriya V Solovyeva; Kristina V Kitaeva; Daria S Chulpanova; Svetlana S Arkhipova; Ivan Yu Filin; Albert A Rizvanov
Journal:  Bionanoscience       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.